What Does Tenaya Therapeutics Do?

Total employees130
HeadquartersSouth San Francisco
Founded2016

Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop, and deliver curative therapies that address the underlying causes of heart disease. They are focused on pioneering genetic medicines, including gene therapy, cellular regeneration, and precision medicine, to improve and save the lives of patients with heart conditions. Tenaya leverages its integrated capabilities in research, development, and manufacturing to advance its pipeline of potentially transformative treatments.

Where Is Tenaya Therapeutics's Headquarters?

Tenaya Therapeutics officeTenaya Therapeutics officeTenaya Therapeutics officeTenaya Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Serves as the central hub for research and development, cGMP manufacturing, corporate operations, and executive leadership.

Notable Features:

State-of-the-art laboratories for gene therapy research, process development, and in-house cGMP manufacturing capabilities for AAV-based gene therapies.

Work Culture:

A science-driven, innovative, and collaborative environment focused on tackling complex challenges in cardiovascular disease. Employees are often mission-oriented, dedicated to patient impact.

HQ Significance:

Located in a prominent biotechnology hub, providing access to talent, research institutions, and industry partners. The co-location of R&D and manufacturing allows for integrated and efficient drug development.

Values Reflected in HQ: Innovation, scientific excellence, patient-centricity, and a commitment to quality are reflected in the advanced facilities and integrated operational model.

Location:

Tenaya Therapeutics' core operations, including research, development, and manufacturing, are primarily based in the United States (South San Francisco, CA). While their physical office presence is centralized, their clinical trials may involve sites across North America and potentially expand globally as programs mature. Their strategic collaborations and future commercialization efforts may also extend their reach internationally.

Street Address:

1000 Gateway Boulevard

City:

South San Francisco

State/Province:

CA

Country:

United States

Where Else Does Tenaya Therapeutics Operate Around the World?

South San Francisco, CA/USA

Address: 1000 Gateway Boulevard, South San Francisco, CA 94080 (Co-located/Part of HQ Campus)

Supports the company's pipeline by providing control over manufacturing processes, quality, and supply chain for its novel gene therapy candidates. Essential for advancing products through clinical development stages.

Buying Intent Signals for Tenaya Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Tenaya Therapeutics? Meet the Executive Team

As of April 2025, Tenaya Therapeutics' leadership includes:

Faraz Ali - Chief Executive Officer
Kaye Foster - Chief People Officer
Matthew Plunkett, Ph.D. - Chief Business Officer
Whit Bernard - General Counsel and Corporate Secretary
Mohamad H. Sater, M.D., Ph.D. - Chief Commercial Officer
Tim Hoey, Ph.D. - Chief Scientific Officer
Sunil Agarwal, M.D. - Chief Development Officer
Leone Patterson - Chief Financial and Business Officer

Who's Investing in Tenaya Therapeutics?

Tenaya Therapeutics has been backed by several prominent investors over the years, including:

The Column Group
Casdin Capital
RTW Investments
RA Capital Management
Fidelity Management & Research Company
GV (formerly Google Ventures)
Biotechnology Value Fund (BVF Partners)
Wellington Management

What Leadership Changes Has Tenaya Therapeutics Seen Recently?

Hire3
Exits0

Tenaya Therapeutics has made several key appointments to its executive team in the past 12-18 months, strengthening its leadership in commercial, legal, and business operations. No prominent executive exits have been publicly announced during this period.

New Appointments:

Mohamad H. Sater, M.D., Ph.D., Dr. Sater appointed as Chief Commercial Officer to lead global commercial strategy and operations.
Matthew Plunkett, Ph.D., Dr. Plunkett appointed as Chief Business Officer to lead corporate strategy and business development.
Whit Bernard, Mr. Bernard appointed as General Counsel and Corporate Secretary, overseeing legal affairs.

What Technology (Tech Stack) Is Used byTenaya Therapeutics?

Discover the tools Tenaya Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Tenaya Therapeutics Email Formats and Examples

Tenaya Therapeutics primarily uses the 'firstinitiallast' email format. Understanding this common pattern can be useful for professional communication.

flast@tenayathera.com

Format

jdoe@tenayathera.com

Example

85%

Success rate

What's the Latest News About Tenaya Therapeutics?

Tenaya Therapeutics Press ReleaseMarch 12, 2024

Tenaya Therapeutics Appoints Mohamad H. Sater, M.D., Ph.D., as Chief Commercial Officer

Tenaya announced the appointment of Mohamad H. Sater, M.D., Ph.D., as Chief Commercial Officer. Dr. Sater brings extensive experience in global commercial strategy and product launches in rare diseases and cardiology....more

Tenaya Therapeutics Press ReleaseFebruary 28, 2024

Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Tenaya provided updates on its gene therapy pipeline, including progress on TN-201 for MYBPC3-Associated HCM, TN-401 for PKP2-Associated ARVC, and its cGMP manufacturing capabilities. Financial results for Q4 and FY2023 were also reported....more

Tenaya Therapeutics Press ReleaseJanuary 8, 2024

Tenaya Therapeutics Highlights 2024 Key Priorities and Expected Milestones

Tenaya outlined its strategic priorities for 2024, focusing on advancing its clinical-stage programs, leveraging its manufacturing capabilities, and progressing its preclinical research....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Tenaya Therapeutics, are just a search away.